Ceftriaxone-Induced Gallbladder Stones in Children

Dr. Hilal AL Hashami; Dr. Maryam Al Saidi; Dr. Samiya Al Hashmi; Dr. Nuha AlTahir

doi:10.34257/GJMRFVOL21IS3PG23

Authors

Dr. Hilal AL Hashami
Dr. Maryam Al Saidi
Dr. Samiya Al Hashmi
Dr. Nuha AlTahir

Keywords:

ceftriaxone, gallbladder stone, child, complication

Abstract

Gallbladder stones in children is one complication that is mostly seen in diseases such as hemolytic diseases, liver disease, and obesity. It can also be a secondary complication of long-duration use of antibiotics like ceftriaxone. However, gallbladder stone, together with sludge themselves, is unusual within the children's population. We observed three children with gallbladder stones who were on a long course of intravenous ceftriaxone. In this study, we present the three cases of children aged between eleven months to seven years who were treated with high doses and for an extended period (more than two weeks) of intravenous ceftriaxone for a complicated systemic bacterial infection. The goal of this study is to raise awareness about the possibility of developing gallbladder stones in pediatric patients who receive a long course of intravenous ceftriaxone.

Downloads

How to Cite

Ceftriaxone-Induced Gallbladder Stones in Children. (2021). Global Journal of Medical Research, 21(F3), 23-27. https://doi.org/10.34257/GJMRFVOL21IS3PG23

Download Citation

References

H Park, S Lee, A Schy (1991) Ceftriaxone associated gallbladder sludge. Identification of calciumceftriaxone salt as a major component of gallbladder precipitate. 100, 1665-1670.

A Unknown Title.

A Nayak, A Slivka (2014) Ceftriaxone-Induced Gallstones: Case Report and Literature Review. 1(3), 170-172.

Setsuki Tsukagoshi, Kunihiko Ishizawa, Kimitoshi Hirayanagi, Shun Nagamine, Kouki Makioka, Yukio Fujita, Yoshio Ikeda (2017) Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections. 56(23), 3189-3192.

Linan Zeng, Chao Wang, Min Jiang, Kexin Chen, Haiqin Zhong, Zhe Chen, Liang Huang, Hailong Li, Lingli Zhang, Imti Choonara (2020) Safety of ceftriaxone in paediatrics: a systematic review. 105(10), 981-985.

Selim Gokce, Mirac Yildirim, Derya Erdogan (2014) A retrospective review of children with gallstone: Single-center experience from Central Anatolia. 25(1), 46-53.

D Meng, Y Cao, J Fu, R Chen, L Lu, Y Tu (2010) Sonographic Assessment of Ceftriaxone-Associated Biliary Pseudolithiasis in Chinese Children. 38(6), 2004-2010.

Filiz Serdaroglu, Yavuz Koca, Fatma Saltik, Tugba Koca, Selim Dereci, Mustafa Akcam, Fusun Akcam (2016) Gallstones in childhood: etiology, clinical features, and prognosis. 28(12), 1468-1472.

Conor Bogue, Amanda Murphy, J Gerstle, Rahim Moineddin, Alan Daneman (2010) Risk Factors, Complications, and Outcomes of Gallstones in Children: A Single‐center Review. 50(3), 303-308.

Isabel Wesdorp, Diederik Bosman, Aafke De Graaff, Daniël Aronson, Frits Van Der Blij, Jan Taminiau (2000) Clinical Presentations and Predisposing Factors of Cholelithiasis and Sludge in Children. 31(4), 411-417.

Ujjal Poddar (2010) Gallstone disease in children. 47(11), 945-953.

Laura Cuzzolin, Anna Oggiano, Maria Clemente, Cristian Locci, Luca Antonucci, Roberto Antonucci (2021) Ceftriaxone‐associated biliary pseudolithiasis in children: do we know enough?. 35(1), 40-52.

L Ustyol, M Bulut, K Agengin, K Bala, A Yavuz, A Bora, K Demiroren, M Dogan (2017) Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children. 36(6), 547-553.

M Dooki, A Norouzi (2013) Choleolithiasis in childhood: a cohort study in north of iran. 23, 588-592.

G Pacifici (2019) Clinical Pharmacology of Ceftriaxone in Infants and Children. 3(1), 2019.

Andrew Fretzayas, Olga Liapi, Anna Papadopoulou, Polyxeni Nicolaidou, Alexandra Stamoulakatou (2011) Is Ceftriaxone-Induced Biliary Pseudolithiasis Influenced by UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms?. 2011, 1-3.